Reports Q4 revenue $735.4M, consensus $741.51M. Eric Evans, Chief Executive Officer, stated, “I am proud of the Company’s continued consistent and predictable growth story. Our long-term growth algorithm strategically positions us to deliver on our commitment of double-digit earnings growth. Supported by our same-facility revenue growth of greater than 11% in 2023, we are reporting top-line growth and margin expansion, consistent with our expectations, and reflecting the positive trajectory that we have experienced all year. This strong growth gives us significant momentum as we enter 2024.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SGRY:
- Is SGRY a Buy, Before Earnings?
- Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details
- Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook
- Surgery Partners reaffirms FY23 revenue guidance $2.75B, consensus $2.75B
- Surgery Partners, Inc. to Present at Upcoming Investor Conference
